Literature DB >> 27816607

PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice.

Radiosa Gallini1, Per Lindblom2, Cecilia Bondjers2, Christer Betsholtz1, Johanna Andrae3.   

Abstract

Platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) contribute to normal heart development. Deficient or abnormal expression of Pdgf and Pdgfr genes have a negative impact on cardiac development and function. The cellular effects of PDGFs in the hearts of Pdgf/Pdgfr mutants and the pathogenesis of the resulting abnormalities are poorly understood, but different PDGF isoforms induce varying effects. Here, we generated three new transgenic mouse types which complete a set of studies, where all different PDGF ligands have been expressed under the same heart specific alpha-myosin heavy chain promoter. Transgenic expression of the natural isoforms of Pdgfa and Pdgfb resulted in isoform specific fibrotic reactions and cardiac hypertrophy. Pdgfa overexpression resulted in a severe fibrotic reaction with up to 8-fold increase in cardiac size, leading to lethal cardiac failure within a few weeks after birth. In contrast, Pdgfb overexpression led to focal fibrosis and moderate cardiac hypertrophy. As PDGF-A and PDGF-B have different affinity for the two PDGF receptors, we analyzed the expression of the receptors and the histology of the fibrotic hearts. Our data suggest that the stronger fibrotic effect generated by Pdgfa overexpression was mediated by Pdgfrα in cardiac interstitial mesenchymal cells, i.e. the likely source of extracellular matrix depostion and fibrotic reaction. The apparent sensitivity of the heart to ectopic PDGFRα agonists supports a role for endogenous PDGFRα agonists in the pathogenesis of cardiac fibrosis.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibrosis; Heart; Myosin heavy chain; PDGF; Transgene

Mesh:

Substances:

Year:  2016        PMID: 27816607     DOI: 10.1016/j.yexcr.2016.10.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  30 in total

1.  Network Analysis Reveals Proteins Associated with Aortic Dilatation in Mucopolysaccharidoses.

Authors:  Thiago Corrêa; Bruno César Feltes; Esteban Alberto Gonzalez; Guilherme Baldo; Ursula Matte
Journal:  Interdiscip Sci       Date:  2021-01-21       Impact factor: 2.233

2.  Non-fibro-adipogenic pericytes from human embryonic stem cells attenuate degeneration of the chronically injured mouse muscle.

Authors:  Gina M Mosich; Regina Husman; Paras Shah; Abhinav Sharma; Kevin Rezzadeh; Temidayo Aderibigbe; Vivian J Hu; Daniel J McClintick; Genbin Wu; Jonathan D Gatto; Haibin Xi; April D Pyle; Bruno Péault; Frank A Petrigliano; Ayelet Dar
Journal:  JCI Insight       Date:  2019-12-19

3.  Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival.

Authors:  Malina J Ivey; Jill T Kuwabara; Kara L Riggsbee; Michelle D Tallquist
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

4.  Myocardial fibrosis, inflammation, and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder.

Authors:  Boyd R Rorabaugh; Nathaniel W Mabe; Sarah L Seeley; Thorne S Stoops; Kasey E Mucher; Connor P Ney; Cassandra S Goodman; Brooke J Hertenstein; Austen E Rush; Charis D Kasler; Aaron M Sargeant; Phillip R Zoladz
Journal:  Stress       Date:  2019-07-26       Impact factor: 3.493

5.  Delineating the molecular and histological events that govern right ventricular recovery using a novel mouse model of pulmonary artery de-banding.

Authors:  Mario Boehm; Xuefei Tian; Yuqiang Mao; Kenzo Ichimura; Melanie J Dufva; Khadem Ali; Svenja Dannewitz Prosseda; Yiwei Shi; Kazuya Kuramoto; Sushma Reddy; Vitaly O Kheyfets; Ross J Metzger; Edda Spiekerkoetter
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

6.  Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies.

Authors:  Eula G A Neves; Carolina C Koh; José L Padilha da Silva; Lívia S A Passos; Fernanda N A Villani; Janete S C Dos Santos; Cristiane A S Menezes; Vicente R Silva; Julia P A S Tormin; Guilherme F B Evangelista; Andréa Teixeira de Carvalho; Manoel Otávio da Costa Rocha; Bruno Nascimento; Kenneth John Gollob; Maria do Carmo P Nunes; Walderez O Dutra
Journal:  Cytokine       Date:  2021-09-27       Impact factor: 3.861

7.  Skeleton-secreted PDGF-BB mediates arterial stiffening.

Authors:  Lakshmi Santhanam; Guanqiao Liu; Sandeep Jandu; Weiping Su; Bulouere P Wodu; William Savage; Alan Poe; Xiaonan Liu; Lacy M Alexander; Xu Cao; Mei Wan
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 19.456

8.  Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.

Authors:  Katsunari Makino; Tomoko Makino; Lukasz Stawski; Julio C Mantero; Robert Lafyatis; Robert Simms; Maria Trojanowska
Journal:  J Invest Dermatol       Date:  2017-04-19       Impact factor: 8.551

Review 9.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

Review 10.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.